10-Feb-15 Encouraged by a relaxation of ownership rules in 2014 and a rapidly ageing population, PE firms and industry players are investing in China’s hospitals, pharmaceutical companies and device makers. The prospect of 223 million people aged 65+ by 2030 is enticing, despite risks such as rising valuations and a dearth of doctors. [image: Reuters]

05-Feb-15 A surge in cancer cases would have a paralysing effect on China’s economy, requiring the nation to spend 100 billion yuan (USD21.5 billion) a year, say health organisations and experts. February 4 marked World Cancer Day, during which the World Health Organisation unveiled that 2.2 million people in China succumb to cancer each year. In all, three million people develop cancer each year in China. [image: MaineNewsOnline]

01-Feb-15 Over ten years the Global Fund initiative in China has successfully addressed several major public health problems. Access to diagnosis and treatment of tuberculosis expanded from two pilot projects in 2006 to 92 sites in 30 provinces by 2013. Between 2002 and 2012 the number of malaria cases fell from over 100,000 to less than 5,000. Finally, China's rate of HIV infection was stabilised at 0.06%. [image: Snipview]

30-Jan-15 China's mobile healthcare market is expected to see fast growth and hit 12.5 billion yuan (USD2 billion) by 2017, according to the China Medical Pharmaceutical Material Association. There are already more than 2,000 mobile healthcare applications in China and 527 million mobile Internet users. [image: mHealthWatch]

25-Jan-15The Chinese pharmaceutical sector saw lower growth in 2014 due to a host of challenges including slowing overall economic growth, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulence. However, the market is still estimated to have grown 13% in 2014, to reach USD200 billion. [image: My Jungle Blog]

For more about China's healthcare sector, request our free 20-page whitepaper: China Healthcare Market Opportunities